Marlise R Luskin

61PUBLICATIONS
352CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (61)

|Sep 25, 2026
Venetoclax plus Inotuzumab Ozogamicin for Relapsed and Refractory Acute Lymphoblastic Leukemia.

|Aug 18, 2026
Blinatumomab administration in the outpatient setting: Safety and health care utilization.

|Jul 07, 2026
Tagraxofusp, Azacitidine, and Venetoclax in Blastic Plasmacytoid Dendritic Cell Neoplasm.

|May 26, 2026
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A Phase I Dose-Escalation Study of Navitoclax, Venetoclax, and Decitabine.

|May 19, 2026
Consensus recommendations for CAR T-cell administration in adult acute lymphoblastic leukemia: a modified Delphi study.

|Mar 30, 2026
Incorporating ALL Biology into Treatment Decisions: Next Steps toward Targeted Therapy in Adult ALL.

Caner Saygin, Matthew T Witkowski, Sinan Cetin

Pageof 11

Frequent Collaborators

21 joint publications

Daniel J DeAngelo

21 joint publications

Shai Shimony

20 joint publications

Jacqueline S Garcia

12 joint publications

Eric S Winer